U.S. markets close in 2 hours 22 minutes
  • S&P 500

    3,274.48
    +27.89 (+0.86%)
     
  • Dow 30

    26,972.79
    +157.35 (+0.59%)
     
  • Nasdaq

    10,819.30
    +147.03 (+1.38%)
     
  • Russell 2000

    1,469.30
    +17.48 (+1.20%)
     
  • Crude Oil

    40.14
    -0.17 (-0.42%)
     
  • Gold

    1,866.90
    -10.00 (-0.53%)
     
  • Silver

    23.09
    -0.10 (-0.44%)
     
  • EUR/USD

    1.1625
    -0.0050 (-0.43%)
     
  • 10-Yr Bond

    0.6610
    -0.0050 (-0.75%)
     
  • GBP/USD

    1.2708
    -0.0044 (-0.34%)
     
  • USD/JPY

    105.6300
    +0.2280 (+0.22%)
     
  • BTC-USD

    10,668.64
    -91.94 (-0.85%)
     
  • CMC Crypto 200

    218.59
    +0.76 (+0.35%)
     
  • FTSE 100

    5,842.67
    +19.89 (+0.34%)
     
  • Nikkei 225

    23,204.62
    +116.80 (+0.51%)
     

Bearish: Analysts Just Cut Their Cutera, Inc. (NASDAQ:CUTR) Revenue and EPS estimates

Simply Wall St

Today is shaping up negative for Cutera, Inc. (NASDAQ:CUTR) shareholders, with the analysts delivering a substantial negative revision to this year's forecasts. Revenue and earnings per share (EPS) forecasts were both revised downwards, with the analysts seeing grey clouds on the horizon.

Following the latest downgrade, the current consensus, from the four analysts covering Cutera, is for revenues of US$131m in 2020, which would reflect a concerning 26% reduction in Cutera's sales over the past 12 months. Per-share losses are expected to explode, reaching US$1.53 per share. However, before this estimates update, the consensus had been expecting revenues of US$149m and US$0.94 per share in losses. Ergo, there's been a clear change in sentiment, with the analysts administering a notable cut to this year's revenue estimates, while at the same time increasing their loss per share forecasts.

View our latest analysis for Cutera

NasdaqGS:CUTR Past and Future Earnings May 8th 2020
NasdaqGS:CUTR Past and Future Earnings May 8th 2020

The consensus price target was broadly unchanged at US$18.33, perhaps implicitly signalling that the weaker earnings outlook is not expected to have a long-term impact on the valuation. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values Cutera at US$26.00 per share, while the most bearish prices it at US$11.00. This is a fairly broad spread of estimates, suggesting that the analysts are forecasting a wide range of possible outcomes for the business.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. These estimates imply that sales are expected to slow, with a forecast revenue decline of 26%, a significant reduction from annual growth of 16% over the last five years. Compare this with our data, which suggests that other companies in the same industry are, in aggregate, expected to see their revenue grow 9.0% next year. It's pretty clear that Cutera's revenues are expected to perform substantially worse than the wider industry.

The Bottom Line

The most important thing to take away is that analysts increased their loss per share estimates for this year. Regrettably, they also downgraded their revenue estimates, and the latest forecasts imply the business will grow sales slower than the wider market. The lack of change in the price target is puzzling in light of the downgrade but, with a serious decline expected this year, we wouldn't be surprised if investors were a bit wary of Cutera.

Even so, the longer term trajectory of the business is much more important for the value creation of shareholders. At Simply Wall St, we have a full range of analyst estimates for Cutera going out to 2022, and you can see them free on our platform here.

Of course, seeing company management invest large sums of money in a stock can be just as useful as knowing whether analysts are downgrading their estimates. So you may also wish to search this free list of stocks that insiders are buying.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.